The trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.

Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.